Skip to content
Zimbabwe’s Medicines Control Authority (MCAZ)
-
Zimbabwe’s Medicines Authority orders recall of Azithromycin over quality concerns
The recall specifically affects Azithromycin 500mg USP Tablets, Batch Number 24050191.
-
Zimbabwe recalls Urografin imaging agent due to cancer-risk impurity
The recall covers all batches of Urografin 60% manufactured between October 2020 and March 2025.
-
ZAMRA approves lenacapavir for HIV prevention in record time
The Zambia Medicines Regulatory Authority (ZAMRA) granted approval on November 4, 2025, completing its review in just 12 working days through an innovative regulatory pathway.